Magnetic resonance imaging-guided focal laser ablation is used as alternative to radical treatment while preserving healthy tissue and subsequently reduce treatment-related morbidity in patients with localized prostate cancer. Preliminary results of this prospective, non-randomized, clinical phase 2 study using a remote-controlled manipulator, show promising results in both oncological and functional outcomes in a group of 20 patients with low- to intermediate-risk (Gleason Score ≤ 4+3) prostate cancer. Transrectal magnetic resonance imaging-guided focal laser ablation is a promising outpatient procedure under local anesthesia for localized prostate cancer. It provides a fast and minimally-invasive strategy while reducing treatment related complications and side-effects.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords